Trials / Completed
CompletedNCT02253537
Evaluation of the QuantiFERON-TB Test.
Evaluation of the 4th Generation QuantiFERON-TB Test (CST001) for the Detection of Tuberculosis Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- QIAGEN Gaithersburg, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Detailed description
To compare the sensitivity of the CST001 assay to the QuantiFERON-TB Gold assay in patients with bacteriologically confirmed and untreated TB disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CST001 |
Timeline
- Start date
- 2015-02-02
- Primary completion
- 2016-04-26
- Completion
- 2016-04-26
- First posted
- 2014-10-01
- Last updated
- 2019-06-18
- Results posted
- 2019-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02253537. Inclusion in this directory is not an endorsement.